Exagen (NASDAQ: XGN)
Exagen Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Exagen Company Info
Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.
News & Analysis
No articles found.
Valuation
Earnings Transcripts
Exagen Inc. (XGN) Q2 2022 Earnings Call Transcript
XGN earnings call for the period ending June 30, 2022.
Exagen Inc. (XGN) Q1 2022 Earnings Call Transcript
XGN earnings call for the period ending March 31, 2022.
Exagen Inc. (XGN) Q4 2021 Earnings Call Transcript
XGN earnings call for the period ending December 31, 2021.
Exagen Inc. (XGN) Q3 2021 Earnings Call Transcript
XGN earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.